Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04936178 · ClinicalTrials.gov registry record · Phase 1

A Study of NB003 in Patients With Advanced Malignancies

A Phase 1 study of Advanced Solid Tumor, sponsored by Ningbo Newbay Technology Development Co..

Completed
Registry status
Phase 1
Development phase
258
Enrollment target
20
Study locations

NCT04936178 is a Phase 1 study of Advanced Solid Tumor that has completed, run by Ningbo Newbay Technology Development Co.. The registered enrollment target is 258 participants, above the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (34% higher). The trial reports 20 study locations across 18 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04936178, a Phase 1 study of Advanced Solid Tumor, has completed, sponsored by Ningbo Newbay Technology Development Co..

COMPLETED
Registry status
Phase 1
Development phase
258 participants
Enrollment target
20
Study locations

Study Summary

This a A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB003 in Subjects with Advanced Malignancies

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG NB003 tablets

Study Locations (20)

Beijing Municipality

  • Beijing Cancer Hospital - Beijing
  • Peking University People's Hospital - Beijing

Guandong

  • Sun Yat-sen University Cancer Center - Guangzhou
  • The First Affiliated Hospital of Sun Yat-sen University - Guangzhou

California

  • Standford University - Stanford

Florida

  • Mayo Clinic - Jacksonville

Massachusetts

  • Dana-Farber Cancer Institute - Boston

New York

  • Memorial Sloan Kettering Cancer Center - Long Island City

Oregon

  • Oregon Health & Science University (OHSU) - Portland

Texas

  • U T MD Anderson Cancer Center Investigational Pharmacy Services - Houston

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2021-08-06
Est. Completion 2025-08-01
Phase Phase 1

Sponsor

Ningbo Newbay Technology Development Co.

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04936178

The ClinicalTrials.gov registry entry for NCT04936178 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (34% higher). The listed sponsor is Ningbo Newbay Technology Development Co., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which NB003 tablets is the first listed.

NCT04936178 reports 20 study locations spanning 18 distinct geographic areas - top geographies include Beijing Municipality, Guandong, California.

Frequently Asked Questions

What is clinical trial NCT04936178 about?

NCT04936178 is a clinical study titled "A Study of NB003 in Patients With Advanced Malignancies". This a A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB003 in Subjects with Advanced Malignancies

What is the current status of trial NCT04936178?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 258 participants. The study started on 2021-08-06. Estimated completion is 2025-08-01.

What conditions does trial NCT04936178 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT04936178?

The interventions under investigation include: NB003 tablets (DRUG).

Who is sponsoring clinical trial NCT04936178?

This trial is sponsored by Ningbo Newbay Technology Development Co., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04936178 being conducted?

This trial has 20 study locations across California, Florida, Massachusetts, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.